[{"address1": "Philip Heymans Alle 3", "city": "Hellerup", "zip": "2900", "country": "Denmark", "phone": "45 33 26 83 83", "website": "https://www.bavarian-nordic.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, Finland, Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.", "fullTimeEmployees": 1667, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul John Chaplin MSc, Ph.D.", "age": 57, "title": "CEO & President", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 3707168, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Henrik  Juuel M.Sc.", "age": 59, "title": "CFO & Executive VP", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1705006, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Russell  Thirsk M.Sc.", "age": 56, "title": "Executive VP & COO", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rolf Sass Sorensen", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nicole  Seroff", "title": "Vice President Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Christophe  May M.B.A., Pharm.D.", "age": 57, "title": "Executive VP & Chief Commercial Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.bavarian-nordic.com/investor.aspx", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 12.325, "open": 12.28, "dayLow": 12.28, "dayHigh": 12.28, "regularMarketPreviousClose": 12.325, "regularMarketOpen": 12.28, "regularMarketDayLow": 12.28, "regularMarketDayHigh": 12.28, "exDividendDate": 1585267200, "payoutRatio": 0.0, "beta": 1.119, "trailingPE": 13.101064, "volume": 200, "regularMarketVolume": 200, "averageVolume": 7592, "averageVolume10days": 4070, "averageDailyVolume10Day": 4070, "bid": 12.29, "ask": 12.34, "bidSize": 2200, "askSize": 160, "marketCap": 2879887360, "fiftyTwoWeekLow": 6.595, "fiftyTwoWeekHigh": 12.979, "priceToSalesTrailing12Months": 0.4461255, "fiftyDayAverage": 10.82506, "twoHundredDayAverage": 9.026845, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -568219584, "profitMargins": 0.22038001, "floatShares": 77679717, "sharesOutstanding": 233574000, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.00021, "impliedSharesOutstanding": 233852000, "bookValue": 154.761, "priceToBook": 0.07957431, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "earningsQuarterlyGrowth": 0.388, "netIncomeToCommon": 1422627968, "trailingEps": 0.94, "enterpriseToRevenue": -0.088, "enterpriseToEbitda": -0.264, "52WeekChange": -0.027251184, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 12.315, "recommendationKey": "none", "totalCash": 1663092992, "totalCashPerShare": 21.361, "ebitda": 2148345088, "totalDebt": 136052000, "quickRatio": 1.584, "currentRatio": 3.345, "totalRevenue": 6455329792, "debtToEquity": 1.129, "revenuePerShare": 27.258047, "returnOnAssets": 0.0688, "returnOnEquity": 0.12652999, "grossProfits": 3427838976, "freeCashflow": -3204626432, "operatingCashflow": 1766713984, "earningsGrowth": 0.364, "revenueGrowth": 0.157, "grossMargins": 0.53101003, "ebitdaMargins": 0.3328, "operatingMargins": 0.22462, "financialCurrency": "DKK", "symbol": "BVNRY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1723728600000, "regularMarketChange": -0.010000229, "regularMarketDayRange": "12.28 - 12.28", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 7592, "fiftyTwoWeekLowChange": 5.72, "fiftyTwoWeekLowChangePercent": 0.8673237, "fiftyTwoWeekRange": "6.595 - 12.979", "fiftyTwoWeekHighChange": -0.6640005, "fiftyTwoWeekHighChangePercent": -0.051159605, "fiftyTwoWeekChangePercent": -2.7251184, "dividendDate": 1586131200, "earningsTimestamp": 1755860340, "earningsTimestampStart": 1755860340, "earningsTimestampEnd": 1755860340, "earningsCallTimestampStart": 1746792000, "earningsCallTimestampEnd": 1746792000, "marketState": "CLOSED", "corporateActions": [], "regularMarketTime": 1756425600, "exchange": "PNK", "messageBoardId": "finmb_7687618", "shortName": "Bavarian Nordic A/S", "longName": "Bavarian Nordic A/S", "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 0.94, "fiftyDayAverageChange": 1.4899397, "fiftyDayAverageChangePercent": 0.137638, "twoHundredDayAverageChange": 3.2881546, "twoHundredDayAverageChangePercent": 0.36426398, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": -0.08113776, "regularMarketPrice": 12.315, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]